An “innate immunity + local immune activation” combination strategy: Systemic IFN-I and topical TLR7/8-based antitumor immunotherapy strategy
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-Dec-2025 03:11 ET (14-Dec-2025 08:11 GMT/UTC)